BioSpace News Archive

Preeminent provider of wearable devices-derived health data & insights draws global investment--leading movement toward greater health and wellness around the world

Ilera Holistic Healthcare (IHH) and PAX Labs are pleased to announce an exclusive partnership in Louisiana that will pair the PAX Era Pro™ inhaler platform with Ilera Holistic’s AYO branded medical cannabis formulations

The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce, according to a new analysis released by Quest Diagnostics, the world’s leading provider of diagnostic information services.

Woebot Heath, a pioneer in the development of relational technologies and tools to support mental health, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s digital therapeutic for the treatment of postpartum depression (PPD).

Jefferies 2021 Virtual Healthcare Conference Fireside Chat Presentation: Wednesday, June 2, 2021 at 1:30 p.m. Eastern Time.

GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that clinicians at Washington University School of Medicine in St. Louis have dosed the first patient in an investigator-sponsored trial (IST) evaluating uproleselan as a prophylactic agent to reduce gastrointestinal (GI) toxicities associated with high-dose melphalan in cell transplantation

Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples

As one of the most important global bio-health conventions, BIO KOREA 2021 International Convention has garnered great attention from home and abroad.

Veracyte, Inc ., (Nasdaq: VCYT) announced today new data that show the company’s Afirma Xpression Atlas (XA) can identify clinically relevant gene fusions in thyroid nodule samples collected via fine needle aspiration (FNA). The findings, which will be presented June 4 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

- Castor is supporting more than 250 COVID-19 studies in 40 countries across 1,750 hospitals - Offers an expanded suite of tools and resources for clinical researchers in the fight against COVID-19 and other pandemic outbreaks